Bridging the Diagnostics Gap: Deloitte Research Exposes Core Mismatch Between Manufacturers and Providers

Why It Matters

The disconnect threatens manufacturers’ revenue streams as providers and patients gravitate toward integrated, consumer‑focused diagnostics, reshaping the industry’s value chain.

Key Takeaways

• 62% of manufacturers see B2B2C as growth driver
• Providers cite test ordering as top workflow friction
• 74% report completely disconnected diagnostic data systems
• 76% expect consumer‑initiated testing to reshape market in 3 years
• Manufacturers must embed AI in EHR workflows to stay relevant

Pulse Analysis

The diagnostics landscape is undergoing a rapid consumerization wave, driven by patients using home testing kits, wearables, and direct‑to‑consumer portals. Deloitte’s research highlights that 76% of providers anticipate these consumer‑initiated demands will fundamentally alter the market within three years, pressuring traditional manufacturers to rethink their go‑to‑market strategies. A B2B2C approach—linking manufacturers, providers, and end‑users—offers a pathway to capture this shift, but only if firms align with the real pain points of clinical workflows.

A deeper dive reveals three core mismatches. Providers identify test ordering as the primary friction, yet manufacturers focus on result interpretation. Likewise, manufacturers target procurement offices, while clinicians and lab directors drive adoption. Finally, high‑frequency field sales clash with providers’ preference for peer‑to‑peer education and digital self‑service tools. These gaps erode trust and limit the value manufacturers can deliver, risking relegation to commodity status.

To stay competitive, manufacturers must embed AI directly into electronic health‑record (EHR) ecosystems, automate prior authorizations, and present personalized, visual data to patients. With 74% of providers reporting fully disconnected diagnostic data stacks, integrated platforms that bridge end‑to‑end workflows become a decisive moat. Companies that invest in interoperable, AI‑enhanced solutions will not only improve provider efficiency but also capture longitudinal patient insights, securing a sustainable revenue stream in the evolving consumer‑centric diagnostics market.